Back
Cytokinetics Stock Price Chart

Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CYTK
Cytokinetics
Last Price:
$44.34
Seasonality Move:
1.46%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.
Cytokinetics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.92 | Buy |
20-day SMA: | 45.21 | Sell |
50-day SMA: | 46.52 | Sell |
200-day SMA: | 51.87 | Sell |
8-day EMA: | 44.34 | Buy |
20-day EMA: | 45.06 | Sell |
50-day EMA: | 46.54 | Sell |
200-day EMA: | 51.11 | Sell |
Cytokinetics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.79 | Sell |
Relative Strength Index (14 RSI): | 46.15 | Sell |
Chaikin Money Flow: | 184584 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.48 - 47.7) | Sell |
Bollinger Bands (100): | (45.4 - 52.8) | Sell |
Cytokinetics Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cytokinetics Stock
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 44.36 while CYTK 8-day simple moving average is 43.92, which is a Buy signal.
-
The stock price of CYTK is 44.36 while Cytokinetics 20-day SMA is 45.21, which makes it a Sell.
-
Cytokinetics 50-day simple moving average is 46.52 while CYTK share price is 44.36, making it a Sell technically.
-
CYTK stock price is 44.36 and Cytokinetics 200-day simple moving average is 51.87, creating a Sell signal.
CYTK Technical Analysis vs Fundamental Analysis
Sell
28
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy or a Sell?
-
Cytokinetics stock is rated a SellThe current Cytokinetics [CYTK] share price is $44.36. The Score for CYTK is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Cytokinetics Stock Info
Market Cap:
5.3B
Price in USD:
44.36
Share Volume:
1.3M
Cytokinetics 52-Week Range
52-Week High:
75.71
52-Week Low:
40.53
Sell
28
Cytokinetics (CYTK)
is a Sell
Cytokinetics Share Price Forecast
-
What is the Cytokinetics stock price today?The Cytokinetics stock price is 44.36 USD today.
-
Will CYTK stock go up or go down?Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cytokinetics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 44.36 while CYTK 8-day exponential moving average is 44.34, which is a Buy signal.
-
The stock price of CYTK is 44.36 while Cytokinetics 20-day EMA is 45.06, which makes it a Sell.
-
Cytokinetics 50-day exponential moving average is 46.54 while CYTK share price is 44.36, making it a Sell technically.
-
CYTK stock price is 44.36 and Cytokinetics 200-day simple moving average is 51.11, creating a Sell signal.
Fundamental Analysis of Cytokinetics
Is Cytokinetics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.44 per share, and an increase next year of $0.87 per share.
Technical Analysis of Cytokinetics
Should I short Cytokinetics stock?
-
CYTK Moving Average Covergence Divergence (MACD) indicator is -0.79, suggesting Cytokinetics is a Sell
-
Cytokinetics Relative Strength Index (RSI) is 46.15, which suggest Cytokinetics is oversold
-
The Bollinger Bands (25) for Cytokinetics is (42.48 - 47.7), which suggest Cytokinetics is a Sell
-
The Bollinger Bands (100) for Cytokinetics is (45.4 - 52.8), which suggest Cytokinetics is a Sell
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.